Hims & Hers Stock Volatility Sparks Investor Debate Amid Telehealth Growth
Hims & Hers Health (HIMS) shares swung wildly after Q2 earnings, defying its 130% year-to-date surge. The telehealth provider posted $544.8 million revenue—a 73% annual jump—but narrowly missed analyst estimates. Subscription growth accelerated, with personalized plans soaring 89% to 1.5 million users.
Dermatology and weight loss segments expanded over 55%, while average revenue per subscriber climbed 30% to $74 monthly. Market reactions highlight the stock's signature volatility, leaving investors weighing its growth trajectory against execution risks in the competitive digital health space.